U.S. Tariffs vs Pharma: A Closer Look

As global trade tensions escalate under the second Trump administration, the U.S. pharmaceutical and clinical research industries are bracing for impact. A new wave of proposed tariffs threatens to raise the cost of critical components, from active pharmaceutical ingredients (APIs) and lab reagents to diagnostic devices, with potentially serious implications for R&D pipelines, drug pricing, […]